The Japan Times - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.202411
AFN 73.235002
ALL 94.010822
AMD 420.942906
ANG 2.048741
AOA 1049.890918
ARS 1708.312595
AUD 1.651213
AWG 2.062583
AZN 1.949836
BAM 1.956929
BBD 2.306993
BDT 141.221492
BGN 1.934858
BHD 0.431849
BIF 3406.765878
BMD 1.14429
BND 1.478053
BOB 7.931577
BRL 5.916437
BSD 1.145441
BTN 109.123599
BWP 15.448995
BYN 3.32335
BYR 22428.090154
BZD 2.30369
CAD 1.624721
CDF 2570.076459
CHF 0.918962
CLF 0.026815
CLP 1055.367966
CNY 7.768706
CNH 7.764588
COP 3833.921811
CRC 521.801106
CUC 1.14429
CUP 30.323693
CVE 110.328665
CZK 24.19568
DJF 203.971962
DKK 7.478628
DOP 67.853899
DZD 152.60404
EGP 56.395058
ERN 17.164355
ETB 183.674631
FJD 2.586612
FKP 0.856767
GBP 0.856761
GEL 3.015251
GGP 0.856767
GHS 13.011508
GIP 0.856767
GMD 82.965454
GNF 10044.796361
GTQ 8.741044
GYD 239.578249
HKD 8.977015
HNL 30.657834
HRK 7.538017
HTG 149.806446
HUF 353.483164
IDR 20590.817625
ILS 3.431327
IMP 0.856767
INR 109.305071
IQD 1500.365788
IRR 1574486.25789
ISK 144.089478
JEP 0.856767
JMD 181.327312
JOD 0.811347
JPY 184.666011
KES 148.094492
KGS 100.065561
KHR 4586.646729
KMF 493.189526
KPW 1029.861683
KRW 1749.900286
KWD 0.355062
KYD 0.954551
KZT 541.642555
LAK 25863.732889
LBP 102571.960304
LKR 383.658213
LRD 207.8945
LSL 18.57902
LTL 3.378792
LVL 0.69217
LYD 7.34175
MAD 10.710881
MDL 20.148035
MGA 4856.141746
MKD 61.673553
MMK 2402.656197
MNT 4102.12012
MOP 9.252339
MRU 45.710377
MUR 53.839292
MVR 17.691161
MWK 1986.285054
MXN 19.989726
MYR 4.65845
MZN 73.132026
NAD 18.57902
NGN 1567.769704
NIO 42.144319
NOK 11.261005
NPR 174.597958
NZD 2.005065
OMR 0.44155
PAB 1.145361
PEN 3.897349
PGK 5.031904
PHP 70.375043
PKR 318.454328
PLN 4.293435
PYG 6964.50578
QAR 4.186916
RON 5.227162
RSD 117.370878
RUB 88.277295
RWF 1676.884883
SAR 4.289743
SBD 9.22131
SCR 15.409196
SDG 687.15054
SEK 11.051625
SGD 1.477627
SHP 0.854328
SLE 27.863894
SLL 23995.199932
SOS 654.623517
SRD 42.986453
STD 23684.499186
STN 24.514146
SVC 10.021783
SYP 126.480809
SZL 18.576018
THB 37.956532
TJS 10.617227
TMT 4.016459
TND 3.380351
TOP 2.755177
TRY 53.515602
TTD 7.763022
TWD 36.546387
TZS 3005.852736
UAH 51.014004
UGX 4180.412311
USD 1.14429
UYU 46.066583
UZS 13720.91767
VES 731.090824
VND 30090.258096
VUV 137.090696
WST 3.173322
XAF 656.381655
XAG 0.018332
XAU 0.000274
XCD 3.092502
XCG 2.064191
XDR 0.816328
XOF 656.381655
XPF 119.331742
YER 271.254434
ZAR 18.573553
ZMK 10299.990075
ZMW 21.046616
ZWL 368.461014
  • CMSC

    0.0400

    21.99

    +0.18%

  • BCC

    0.4500

    75.93

    +0.59%

  • RIO

    1.0700

    94.42

    +1.13%

  • AZN

    11.2900

    195.15

    +5.79%

  • CMSD

    -0.0300

    22.15

    -0.14%

  • NGG

    2.6700

    82.85

    +3.22%

  • JRI

    0.0600

    13

    +0.46%

  • GSK

    2.3600

    53.66

    +4.4%

  • BCE

    0.4000

    21.42

    +1.87%

  • RELX

    0.5500

    31.93

    +1.72%

  • RBGPF

    2.5400

    68.15

    +3.73%

  • BP

    1.2500

    37.4

    +3.34%

  • RYCEF

    0.5400

    19.68

    +2.74%

  • BTI

    1.2100

    61.77

    +1.96%

  • VOD

    0.1400

    13.15

    +1.06%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

T.Shimizu--JT